Background: Food allergy to wheat-derived foodstuffs is on the rise. Tri a 14, a wheat flour lipid transfer protein (LTP) allergen, has been described as a major allergen associated with baker’s asthma and wheat food allergy. Cross-reactivity among LTP allergens leads to the so-called ‘LTP syndrome’. Methods: Eight adult patients showing anaphylaxis after ingestion of wheat-derived foodstuffs were selected. A homemade wheat extract, purified natural (n) and recombinant (r) Tri a 14, and peach fruit and Artemisia pollen LTP allergens Pru p 3 and Art v 3 were subjected to skin prick test, specific IgE determination (ELISA) and IgE immunodetection assays. Results: All tests were positive in the 8 selected patients with the homemade extract. Positive skin prick test responses to nTri a 14, Pru p 3 and Art v 3 were found in 5/8, 6/8 and 4/4 patients, respectively. Specific IgE determined by ELISA assays was detected in 6 to nTri a 14 and rTri a 14, in 4 to Pru p 3 and in 3 to Art v 3 out of 8 individual sera tested, whereas all these sera showed IgE binding to nTri a 14 and Pru p 3 in immunodetection after SDS-PAGE separation. Conclusions: Tri a 14 seems to be a relevant allergen in patients with anaphylaxis after ingestion of wheat flour foodstuffs, according to in vitro and in vivo results. Clinical history of the analyzed patients, together with sensitization to peach Pru p 3 and Artemisia pollen Art v 3, suggests that 6 of them suffer from LTP syndrome.

Keywords:
Wheat food allergy, Lipid transfer protein, Tri a 14, Anaphylaxis, Pollen food cross-reactions, Peach Pru p 3
1.
Shewry PR: Wheat. J Exp Bot 2009;60:1537–1553.
2.
Palouso K: Update on wheat hypersensitivity. Curr Opin Allergy Clin Immunol 2003;3:205–209.
3.
Battais F, Courcoux P, Popineau Y, Kanny G, Moneret-Vautrin DA, Denery-Papini S: Food allergy to wheat: differences in immunoglobulin E-binding proteins as a function of age or symptoms. J Cereal Sci 2005;42:109–117.
4.
Scibilia J, Pastorello EA, Zisa G, et al: Wheat allergy: a double-blind, placebo-controlled study in adults. J Allergy Clin Immunol 2006;117:433–439.
5.
Pastorello EA, Farioli L, Conti A, et al: Wheat IgE-mediated food allergy in European patients: α-amylase inhibitors, lipid transfer proteins and low-molecular-weight glutenins. Int Arch Allergy Immunol 2007;144:10–22.
6.
Salvatori N, Reccardini F, Convento M, et al: Asthma induced by inhalation of flour in adults with food allergy to wheat. Clin Exp Allergy 2008;38:1349–1356.
7.
Tatham AS, Shewry PR: Allergens in wheat and related cereals. Clin Exp Allergy 2008;38:1712–1726.
8.
Sanchez-Monge R, Gomez L, Barber D, et al: Wheat and barley allergens associated with baker’s asthma. Glycosylated subunits of the α-amylase-inhibitor family have enhanced IgE-binding capacity. Biochem J 1992;28:401–405.
9.
James JM, Sixbey JP, Helm RM, et al: Wheat alpha-amylase inhibitor: a second route of allergic sensitization. J Allergy Clin Immunol 1997;99:239–244.
10.
Palacin A, Quirce S, Armentia A, et al: Wheat lipid transfer protein is a major allergen associated with baker’s asthma. J Allergy Clin Immunol 2007;120:1132–1138.
11.
Palacin A, Varela J, Quirce S, et al: Recombinant lipid transfer protein Tri a 14: a novel heat and proteolytic resistant tool for the diagnosis of baker’s asthma. Clin Exp Allergy 2009;39:1267–1276.
12.
Salcedo G, Sanchez-Monge R, Barber D, Diaz-Perales A: Plant non-specific lipid transfer proteins: an interface between plant defence and human allergy. Biochim Biophys Acta 2007;1771:781–791.
13.
Fernández-Rivas M, González-Mancebo E, Rodríguez-Pérez R, et al: Clinically relevant peach allergy is related to peach lipid transfer protein, Pru p 3, in the Spanish population. J Allergy Clin Immunol 2003;112:789–795.
14.
Asero R, Antonicelli L, Arena A, et al: EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study. Clin Exp Allergy 2009;39:547–555.
15.
van Ree R: Clinical importance of non-specific lipid transfer proteins as food allergens. Biochem Soc Trans 2002;30:910–913.
16.
Zuidmeer L, van Ree R: Lipid transfer protein allergy: primary food allergy or pollen/food syndrome in some cases. Curr Opin Allergy Clin Immunol 2007;7:269–273.
17.
Diaz-Perales A, Lombardero M, Sanchez-Monge R, et al: Lipid-transfer proteins as potential plant panallergens: cross-reactivity among proteins of Artemisia pollen, Castanea nut and Rosaceae fruits, with different IgE-binding capacities. Clin Exp Allergy 2000;30:1403–1410.
18.
Asero R, Mistrello G, Roncarolo D, et al: Immunological cross-reactivity between lipid transfer proteins from botanically unrelated plant-derived foods: a clinical study. Allergy 2002;57:900–906.
19.
Pastorello EA, Robino AM: Clinical role of lipid transfer proteins in food allergy. Mol Nutr Food Res 2004;48:356–362.
20.
Lombardero M, Garcia-Selles FJ, Polo F, et al: Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens. Clin Exp Allergy 2004;34:1415–1421.
21.
Palacin A, Cumplido J, Figueroa J, et al: Cabbage lipid transfer protein Bra o 3 is a major allergen responsible for cross-reactivity between plant foods and pollens. J Allergy Clin Immunol 2006;117:1423–1429.
22.
Lauer I, Miguel-Moncin MS, Abel T, et al: Identification of a plane pollen lipid transfer protein (Pla a 3) and its immunological relation to the peach lipid-transfer protein, Pru p 3. Clin Exp Allergy 2007;37:261–269.
23.
Diaz-Perales A, Sanz ML, Garcia-Casado G, et al: Recombinant Pru p 3 and natural Pru p 3, a major peach allergen, show equivalent immunologic reactivity: a new tool for the diagnosis of fruit allergy. J Allergy Clin Immunol 2003;111:628–633.
24.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
25.
Baur X, Degens PO, Sander I: Baker’s asthma: still among the most frequent occupational respiratory disorders. J Allergy Clin Immunol 1998;102:984–997.
26.
Lehto M, Palosuo K, Varjonen E, et al: Humoral and cellular responses to gliadin in wheat-dependent, exercise-induced anaphylaxis. Clin Exp Allergy 2003;33:90–95.
27.
Pastorello EA, Vieths S, Pravettoni V, et al: Identification of hazelnut major allergens in sensitive patients with positive double-blind, placebo-controlled food challenge results. J Allergy Clin Immunol 2002;109:563–570.
28.
Pastorello EA, Farioli L, Pravettoni V, et al: Lipid transfer protein and vicilin are important walnut allergens in patients not allergic to pollen. J Allergy Clin Immunol 2004;114:908–914.
29.
San Miguel-Moncín M, Krail M, Scheurer S, et al: Lettuce anaphylaxis: identification of a lipid transfer protein as the major allergen. Allergy 2003;58:511–517.
30.
Sánchez-Monge R, Lombardero M, García-Sellés FJ, Barber D, Salcedo G: Lipid-transfer proteins are relevant allergens in fruit allergy. J Allergy Clin Immunol 1999;103:514–519.
31.
Pastorello EA, Farioli L, Pravettoni V, et al: The maize major allergen, which is responsible for food-induced allergic reactions, is a lipid transfer protein. J Allergy Clin Immunol 2000;106:744–751.
32.
Palacin A, Rodriguez J, Blanco C, et al: Immunoglobulin E recognition patterns to purified kiwifruit (Actinidinia deliciosa) allergens in patients sensitized to kiwi with different clinical symptoms. Clin Exp Allergy 2008;38:1220–1228.
33.
Palacin A, Quirce S, Sánchez-Monge R, et al: Allergy to kiwi in patients with baker’s asthma: identification of potential cross-reactive allergens. Ann Allergy Asthma Immunol 2008;101:200–205.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.